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Introduction
The sarcomeric protein titin alias connectin is, after actin and 
myosin, the third most abundant protein in vertebrate striated 
muscle  and  expressed  from  mid-gestation  through  adult  life 
(Fürst et al., 1989; Schaart et al., 1989). Its functional domains 
are assembled into various titin isoforms to adjust its mechanical 
and  structural  properties  depending  on  developmental  stage, 
functional requirements, and underlying disease (Neagoe et al., 
2002; Lahmers et al., 2004; Opitz et al., 2004; Warren et al., 
2004). The large cardiac titin N2BA isoform (3.5–3.7 MDa) is 
rapidly replaced by the smaller N2B isoform (3.0 MDa) both 
after birth and with reexpression of the fetal gene program in 
cardiac pathology (Neagoe et al., 2002; Lahmers et al., 2004; 
Makarenko et al., 2004; Opitz et al., 2004; Warren et al., 2004). 
This change in titin isoform expression helps adapt the elastic 
properties of the myocardium to enable efficient filling of the 
cardiac ventricle in diastole and has been characterized in detail 
both on the molecular and functional level (Lahmers et al., 
2004; Opitz et al., 2004). Nevertheless, there is a gap in knowl-
edge on how the altered titin isoform makeup is translated into 
altered sarcomeric protein composition, i.e., how titin mole-
cules are replaced and relocalized in the working sarcomere to 
adapt cardiac function.
Although the maintenance and remodeling of preexisting 
sarcomeres and the balance of assembly and disassembly in the 
working myocardium are still only poorly understood, there has 
been considerable progress toward elucidating de novo sarco-
mere assembly during embryonic development (Dabiri et al., 
1997; Du et al., 2003; Wang et al., 2005a,b; Weinert et al., 2006; 
Stout et al., 2008; Sanger et al., 2009). According to the pre-
myofibril model, the initial formation of regular sarcomeres in-
volves the polymerization of actin, incorporation of myosin, as 
well as assembly and alignment of Z-bodies, which incorporate 
titin’s N terminus and form the future Z-disc (Rhee et al., 1994; 
Sanger et al., 2000; Du et al., 2003). Subsequently titin’s   
C terminus is integrated into the M-band and connected to the 
muscle myosin filament (Nave et al., 1989; Obermann et al., 
1996). The resulting continuous filament system has been re-
garded as a molecular ruler and as a blueprint for sarcomere   
assembly because titin’s PEVK-region, immunoglobulin, fibro-
nectin, and kinase domains are associated with specific sec-
tions of the half-sarcomere and thus sublocalize the various 
titin-binding  proteins  along  the  myofilament  (Labeit  and   
Kolmerer, 1995; Trinick, 1996; van der Loop et al., 1996;   
Obermann et al., 1997; Gregorio et al., 1998). Within the   
T
he giant muscle protein titin is an essential structural 
component of the sarcomere. It forms a continuous 
periodic backbone along the myofiber that provides 
resistance to mechanical strain. Thus, the titin filament has 
been regarded as a blueprint for sarcomere assembly and 
a prerequisite for stability. Here, a novel titin-eGFP knockin 
mouse provided evidence that sarcomeric titin is more 
dynamic than previously suggested. To study the mobility 
of titin in embryonic and neonatal cardiomyocytes, we 
used fluorescence recovery after photobleaching and   
investigated the contribution of protein synthesis, contrac-
tility, and calcium load to titin motility. Overall, the kinetics 
of lateral and longitudinal movement of titin-eGFP were simi-
lar. Whereas protein synthesis and developmental stage 
did not alter titin dynamics, there was a strong, inhibitory 
effect of calcium on titin mobility. Our results suggest a model 
in which the largely unrestricted movement of titin within 
and between sarcomeres primarily depends on calcium, 
suggesting that fortification of the titin filament system is 
activity dependent.
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proteins has been investigated and related to sarcomere stability, 
stress, and signal transduction (McElhinny et al., 2002; Pizon 
et al., 2002; Miller et al., 2003), it has so far not been possible 
to obtain similar data for titin itself based on technical chal-
lenges related to titin’s exceptional size.
Here, we have generated a titin-eGFP knockin mouse and 
used fluorescence recovery after photobleaching (FRAP) to 
study titin dynamics in living cells. We were able to dissect titin 
mobility from de novo protein synthesis and demonstrated that 
the migration of titin molecules depends on calcium. We show 
that titin moves equally efficient within and between adjacent 
sarcomeres and that this process does not depend on cardio-
myocyte contraction or major rearrangements of the myofila-
ment. Furthermore, we provide evidence that titin dynamics are 
independent from the developmental stage as embryonic and 
neonatal cardiomyocytes display similar titin mobility. Our data 
suggest that titin molecules are rapidly exchanged between a 
pool of sarcomeric (bound) and nonsarcomeric (free) titin and 
that its mobility is inversely correlated with calcium levels but 
maintained from embryonic to postnatal development.
Results
Generation and validation of  
the animal model
Due to its size of up to 3.7 MDa, titin is not readily available for 
overexpression, gain-of-function studies, or the generation of a 
tagged full-length protein. To circumvent this problem, we have 
used gene targeting of the titin locus and generated a fluores-
cently labeled titin protein for expression analysis and real-time 
imaging. The targeting vector (Fig. 1 A) was designed to inte-
grate eGFP into titin’s M-band exon 6 with a Neo resistance 
gene inserted into the 3-untranslated region. After electropora-
tion, selection, and verification of the targeted allele, positive 
embryonic stem cells were injected into blastocysts as de-
scribed previously (Gotthardt et al., 2003). After germline trans-
mission and excision of the Neo resistance cassette, subsequent 
generations were bred to hetero- or homozygosity as experi-
ments warranted. Knockin, heterozygous, and wild-type animals 
were born at the expected Mendelian ratios. Both hetero- and 
homozygotes were viable and fertile, without any obvious   
phenotypic defects or changes in heart to body weight ratio 
(Fig. 1, B and C). Expression of titin-eGFP was confirmed by 
qPCR and Western blot, which both resulted in a strong signal 
in homozygote and an intermediate expression in heterozy-
gote animals (Fig. 1, D and E; Fig. S1). The robust expression 
of titin-eGFP protein allowed for the detection of the native 
eGFP-fusion protein even in heterozygotes (Fig. 1 F). The peri-
odic distribution of the fluorescent signal as detected by con-
focal imaging suggested proper integration of titin-eGFP into 
the sarcomere, which was confirmed by coimmunofluorescence 
staining (Fig. 2). The alternating signal of titin-eGFP at the   
M-band and the Z1/Z2 titin epitope or -actinin at the Z-disc 
documented proper integration of the extended titin molecule in 
the Z-disc and M-band of the sarcomere and the expected local-
ization of the eGFP-tag at the M-band in heart, quadriceps, 
and soleus muscle.
Z-disc, titin binds to T-cap alias telethonin (Gregorio et al., 
1998), which assembles titin’s N terminus into an antiparallel 
sandwich complex (Zou et al., 2006). Titin’s structural relations 
to the thin filament are mediated by -actinin, which connects 
to titin in the Z-disc (Ohtsuka et al., 1997a,b; Sorimachi et al., 
1997). The interaction between titin’s PEVK region and actin 
within the I-band is calcium dependent and has been related to 
the passive properties of the sarcomere and its relaxation kinetics 
(Kulke et al., 2001; Yamasaki et al., 2001). Within the A-band 
titin is tightly linked to the thick filament via its multiple bind-
ing sites for myosin-binding protein C (MyBP-C; Labeit et al., 
1992; Houmeida et al., 1995; Freiburg and Gautel, 1996). The 
titin–myosin interaction is reinforced at the M-band where titin 
interacts with myomesin and M-protein—both relevant for 
the assembly and structural maintenance of thick filaments 
(Bähler et al., 1985; Nave et al., 1989; Vinkemeier et al., 1993; 
Obermann et al., 1996). Thus, titin’s integration into the sarco-
meric lattice is mediated by its interaction with multiple struc-
tural proteins along the half-sarcomere and provides an elastic 
connection between the thick and thin filament systems, thereby 
centering the A-band in the sarcomere (Houmeida et al., 1995).
In addition to its structural functions, titin relates to signal 
transduction and metabolism through its kinase domain, phos-
phorylation sites, and interaction with adaptor and signaling 
proteins. Four-and-a-half LIM domain protein 2 (FHL2) re-
cruits metabolic enzymes to sites of high energy consumption 
such as the M-band and the cardiac N2B region within the   
I-band (Lange et al., 2002). Titin’s N2A region binds muscle 
ankyrin repeat proteins, which link myofibrillar stretch-induced 
signaling pathways and muscle gene expression (Miller et al., 
2003) and the protease calpain 3 (p94), which has been sug-
gested to play a role in myofibrillogenesis and sarcomere re-
modeling (Sorimachi et al., 1995; Kramerova et al., 2004). 
Additional binding sites for proteins related to signal transduc-
tion and protein degradation, such as MuRF (muscle-specific 
RING finger protein) 1 and 2 and calpain 3 are located at titin’s 
M-band (Kinbara et al., 1997; Centner et al., 2001; Lange et al., 
2002; Witt et al., 2005). Thus, multiple binding proteins inte-
grate titin into the sarcomere and decorate the titin filament with 
links to basic cellular functions such as trophic signaling and 
energy balance.
Although the mature myofibril appears as a stable struc-
ture, it is crucial that its components can readily detach, not 
only to replace proteins but also to adapt in conditions that re-
quire atrophy or hypertrophy. Thus, cardiac proteins are actively 
exchanged between organized structures such as the sarcomere 
and cytoplasmic pools (McKenna et al., 1985a; Sanger et al., 
1986; Mittal et al., 1987). Within a few hours after injection, 
fluorescently labeled proteins are properly incorporated into the 
sarcomere (McKenna et al., 1985b; Mittal et al., 1987; Dome   
et al., 1988). The dynamics of proteins within the sarcomere as 
determined by photobleaching (exchange of bleached by neigh-
boring fluorescent molecules) was reported to be much faster 
than expected based on their protein half-lives in the order of 
several days (Zak et al., 1977; Suzuki et al., 1998; Hasebe-Kishi 
and Shimada, 2000; Wang et al., 2005a; Skwarek-Maruszewska 
et al., 2009). Although the mobility of various titin-binding 787 Visualizing titin dynamics • da Silva Lopes et al.
was used to assess the quality of the culture. We used FRAP as 
a parameter of titin mobility with a minimal region of interest 
(ROI) that comprises one sarcomere length to reduce photo-
toxicity. Our preliminary analysis indicated stable recovery within 
14 h. Calculated half-fluorescence mobility and mobile frac-
tions did not change with an additional incubation through 24 h. 
Although myocytes contract and shift position in culture over 
time, the area of photobleaching was stable throughout the 
experiment. Based on these experiments we used homozygous 
titin-eGFP knockin cardiomyocytes to increase the signal-to-noise 
ratio and followed the exchange of bleached by unbleached 
titin-eGFP molecules for 14 h to reach a steady state of recovery 
(Fig. 3 A) and reduce the possibility for changes in the cellular 
phenotype in culture. To distinguish changes in the eGFP signal 
The expression of titin-eGFP from the endogenous pro-
moter at physiological levels, the proper assembly of the eGFP-
tagged sarcomeres, and the lack of an apparent phenotype in 
hetero- or homozygote animals make the established animal model 
a suitable tool not only to follow expression and localization of 
titin in different muscle types (skeletal muscle and heart), but 
also to investigate titin dynamics in living cardiomyocytes.
Kinetics of titin-eGFP mobility in  
embryonic cardiomyocytes
To facilitate real-time imaging and obtain a baseline reading of 
titin’s mobility, we used primary cultures of embryonic cardio-
myocytes isolated at embryonic day 13.5 (E13.5). The continued 
and regular beating of cardiomyocytes after isolation and plating 
Figure 1.  Generation of the titin-eGFP knockin mouse. (A) Targeting strategy to insert eGFP into titin’s M-band exon 6 (MEx6). The targeting vector was 
linearized with PmlI and contains the FRT flanked Neo selectable marker. Locations of the genotyping primers are indicated in the wild-type, targeted, and 
knockin allele (black arrows). Germline expression of the Flp recombinase was used to excise the Neo cassette (open arrow). (B) PCR-based genotyping of 
wild-type (+/+), heterozygous (G/+), and homozygous (G/G) titin-eGFP knockin mice. The targeted allele (T) and the excision of the Neo cassette (RECf 
allele) after introduction of the Flp transgene (Flp) were confirmed by PCR. Homozygous knockin animals are viable as documented by the absence of 
the wild-type allele in the GFP-positive animal (G/G Flp). Bp, base pair. (C) Heart to body weight ratio of female heterozygous (G/+) and homozygous 
(G/G) titin-eGFP knockin mice was unchanged compared with wild-type (+/+; n = 6 per group). (D) Expression analysis of titin-eGFP in heart and skeletal 
muscle (quadriceps and soleus) using qRT-PCR confirmed the expected intermediate titin-eGFP mRNA levels in heterozygous (G/+) versus homozygous 
animals (G/G). Soleus muscle mRNA levels were increased as compared with heart and quadriceps. Data were normalized to 18S RNA and titin levels 
in homozygous hearts were set as 1 (n = 5 per group). f.c., fold change. ***, P < 0.001. (E) Western blot using an anti-GFP antibody detects the high 
molecular weight titin-eGFP fusion protein (T1, full length; T2, degradation product). (F) The eGFP-tagged titin protein was integrated into the sarcomere as 
indicated by confocal imaging of native cardiac tissue. In both hetero- and homozygotes, the fluorescent signal was sufficiently strong for detection without 
amplification. Bar, 10 µm. Error bars indicate SEM.JCB • VOLUME 193 • NUMBER 4 • 2011   788
as compared with CX-treated cells resulted in similar kinetics 
with complete fluorescence recovery after 14 h. Analysis of the 
recovery profile indicated no significant change in mobile frac-
tions (49 ± 4% vs. 53 ± 9%) or half-lives of fluorescence recov-
ery (2.2 vs. 2.6 h) in control compared with CX-treated cells 
(Fig. 3, B and C; Table I).
To dissect the contribution of sarcomere rearrangement 
versus  molecular  movement  of  titin-eGFP,  we  increased  the 
ROI as indicated in Fig. 4. The mobile fraction was unchanged 
that result from protein synthesis versus protein mobility, we 
used cycloheximide (CX) as an inhibitor of protein synthesis 
that blocks translation elongation and has been applied to em-
bryonic as well as to neonatal cardiomyocytes (Zaal et al., 1999; 
Wang et al., 2005a; Stahlhut et al., 2006). CX was added to the 
media 1 h before photobleaching and continued throughout the 
experiment. Fluorescence recovery rates were obtained by plot-
ting the green fluorescence signal as a function of time after photo-
bleaching. FRAP analysis of control cells (without treatment) 
Figure 2.  Integration of titin-eGFP into the sarcomere. Expression and localization of titin-eGFP were documented in the heart, quadriceps, and soleus of 
homozygous, adult knockin mice. Coimmunofluorescence staining with antibodies directed against the Z-disc protein -actinin (A), titin’s Z1/Z2 epitope (B), 
and titin’s M-band epitope M8/M9 (C) confirmed that titin-eGFP was properly integrated into the Z-disc and M-band of the sarcomere where it colocalized 
with the M8/M9 epitope in all striated muscle tissues analyzed. Bar, 10 µm.
Figure 3.  Titin-eGFP dynamics are independent 
from protein synthesis. Cells were imaged for 14 h   
after  photobleaching  to  follow  recovery  and 
treated  with  cycloheximide  (CX)  to  distinguish 
titin mobility and de novo synthesis. (A) Images 
of control and CX-treated embryonic cardiomyo-
cytes (E13.5) from homozygous titin-eGFP knockin 
mice were obtained before and immediately after 
bleaching (white arrows). Titin-eGFP was homog-
enously distributed in embryonic cardiomyocytes 
and fluorescence had significantly recovered after 
14 h. Bar, 10 µm. (B) Plot of fluorescence inten-
sity vs. time after photobleaching to compare titin-
eGFP protein recovery of control and CX-treated 
cells. Inhibition of protein synthesis did not influ-
ence the mobility of titin-eGFP (control, n = 4; CX, 
n = 3). (C) Quantification of the titin-eGFP mobile 
fractions indicated a level of 50% in both control 
and CX-treated cardiomyocytes (control, n = 4; CX, 
n = 3). Error bars indicate SEM.789 Visualizing titin dynamics • da Silva Lopes et al.
indicate that fluorescence recovery cannot solely be explained 
by rearrangement of myofibers but relates to the movement of 
individual titin-eGFP molecules.
Taken together, these data suggest that the titin filament 
system is not a rigid structure but contains a pool of titin mole-
cules that migrate—albeit at a slower pace than other sarcomeric 
proteins—within the sarcomeric structure. Importantly, inhibi-
tion of protein synthesis revealed the same size of the dynamic 
titin pool and did not influence the mobility so that the changes 
in fluorescence are attributable to changes in titin mobility and 
not de novo synthesis of titin protein.
Longitudinal and lateral dynamics of  
titin-eGFP
Titin molecules are integrated into the M-band and Z-disc (Fürst 
et al., 1988; Wang et al., 1991; Labeit et al., 1997) and longitu-
dinal movement along the sarcomere would require titin to dis-
connect, whereas lateral movement would retain titin within the 
half-sarcomere and merely require neighboring titin molecules 
to exchange positions. Conceivably, this could result in differ-
ent kinetics for lateral and longitudinal diffusion of titin. To 
compare the mobility of titin within the myofibril (lateral move-
ment) and between adjacent myofibrils (longitudinal movement), 
we followed titin movement in the photobleached area of 8 × 8 
sarcomere lengths (Fig. S2; Video 1) and did not detect major 
differences in repopulation from lateral versus longitudinal. 
Furthermore, we altered the shape of the bleached area as indicated 
between small, medium, and large bleached areas, suggesting 
that  the  relative  amount  of  titin-eGFP  that  can  move  into  the 
bleached ROI is independent from the size of the area. The cal-
culated exchange half-life is increased with the area of inter-
est (Table II)—possibly reflecting the larger distance adjacent 
fluorescent molecules have to travel to completely fill the cen-
tral photobleached area. Fluorescence recovery is indeed slightly 
faster at the edges of the bleached area (Fig. S2 and Video 1). 
Importantly, filament direction and spacing were remarkably con-
served over the 14-h imaging period (Fig. 4; Fig. S2). This would 
Table I.  Mobile fractions (Mf) and exchange half-lives (t1/2) of titin-
eGFP (FRAP analysis)
Treatment or cell type Mf [%] t1/2 [h]
Control 49 ± 4 2.1 ± 0.4
CX 53 ± 9 2.6 ± 0.4
LCa 72 ± 4** 3.6 ± 0.6
HCa 28 ± 5* 2.9 ± 0.9
BDM 38 ± 1 2.3 ± 0.3
BDM + HCa 24 ± 1* 1.7 ± 0.8
NCM 56 ± 3 3.7 ± 0.4
Control, embryonic cardiomyocytes without treatment at normal calcium (NCa); 
CX, cycloheximide treatment; LCa, low calcium concentration; HCa, high cal-
cium concentration; BDM, 2,3-butanedione monoxime; NCM, neonatal cardio-
myocytes (n = 24).
*, P < 0.05.
**, P < 0.01; one-way ANOVA, posttest Dunnett (comparison vs. control). Data 
are indicated as means ± SEM.
Figure 4.  Myofibril structure is maintained dur-
ing FRAP. (A) We followed fluorescence recovery 
in areas of 3 × 3 or 8 × 8 sarcomere lengths to 
distinguish movement of titin-eGFP from myofibril 
rearrangement.  Bar,  10  µm.  (B)  Comparison  of 
fluorescence recovery for 1 × 1 (control), 3 × 3, or   
8 × 8 sarcomere lengths. As the region of interest   
increases in size recovery takes longer, empha-
sized  in  the  center  of  the  photobleached  area   
(A, recovery at 8 × 8). (C) The mobile fractions 
were independent from the size of the bleached 
area. The recovery was homogeneous and sarco-
mere structure maintained over the region of inter-
est (control, n = 4; 3 × 3, n = 4; 8 × 8, n = 3).   
s.l., sarcomere length. Error bars indicate SEM.JCB • VOLUME 193 • NUMBER 4 • 2011   790
N2B in neonatal compared with embryonic cultured cardiomyo-
cytes (Fig. S3). Together with the altered isoform expression 
of sarcomeric titin-binding proteins such as myomesin (Grove 
et al., 1985), this might have implications for retention of titin 
in the M-band and altered motility in embryonic versus neona-
tal cardiomyocytes. To investigate whether the dynamic proper-
ties of titin protein change postnatally, we performed FRAP 
analysis on neonatal cardiomyocytes (NCM, P2). The compari-
son to embryonic cardiomyocytes did not indicate any major 
change in fluorescence recovery of titin (Fig. 8, A and B): mobile 
fractions of 56 ± 3% and exchange half-lives of titin mobility   
(3.7 ± 0.4) were not significantly different from those calcu-
lated for embryonic cardiomyocytes (Fig. 8 C; Table I). Thus, 
changes in perinatal isoform expression do not exert a discernable 
effect on titin mobility.
Discussion
Due to titin’s size and its expression in multiple isoforms it 
has been notoriously difficult to study the holoprotein both in 
vitro and in cultured cells. Circumventing the problems asso-
ciated with the analysis of individual titin domains outside 
their native environment such as dominant-negative effects 
and mislocalization, researchers have used tissue- and species-
specific titin isoform expression and subsequently knockout 
technology to gain insight into titin’s roles in sarcomere as-
sembly and stability and mechanotransduction, as well as in 
cardiac and skeletal muscle physiology (Weinert et al., 2006; 
Radke et al., 2007; Gramlich et al., 2009; Granzier et al., 
2009). Based on these studies it has been proposed that titin 
serves as an elastic scaffold to provide both a backbone for 
proper assembly and localization of sarcomeric proteins and a 
mechanical basis for the passive functions of striated muscle 
(Tskhovrebova and Trinick, 2003). Earlier work has shown 
that the accumulation of transfected titin fragments, which 
consist of the Z-disc region of titin fused to GFP, leads to dis-
assembly of the sarcomere (Turnacioglu et al., 1997). In this 
study, we have used the titin-eGFP knockin mouse to prevent 
this toxic side effect and to constitutively express titin-eGFP 
in cardiomyocytes at physiological levels. We asked how sta-
ble the titin scaffold is over time using the titin-eGFP mouse 
as a novel animal model to investigate the mobility of the titin 
protein. The knockin allows us to study the dynamics of titin 
mobility and to follow titin-eGFP’s replacement after photo-
bleaching in living cardiomyocytes.
Minimally invasive labeling of titin
Although the addition of the eGFP-tag only results in a minor 
addition to titin’s molecular weight (<1%), we considered 
the possibility of steric hindrance of protein interactions and 
avoided manipulating titin’s N terminus, which binds T-cap 
and is a crucial component of the Z-disc structure (Gregorio 
et al., 1998). Integration of titin in the M-band involves myo-
mesin, which interacts with the Ig domain M4 (Obermann   
et al., 1997). There are no known interacting proteins at the very 
C terminus, which is thus amenable to addition of a protein 
tag. Indeed, the C-terminal fusion of eGFP did not affect the 
in Fig. 5 A with bleaching of 3 or 8 consecutive sarcomeres 
along or across the myofiber. Lateral and longitudinal movement 
were equally efficient as indicated in Fig. 5, B and C. Comparison 
of the mobile fractions longitudinal versus lateral for 3 sarco-
meres (62 ± 5 and 58 ± 8, respectively) and longitudinal versus 
lateral for 8 sarcomeres (59 ± 1 and 47 ± 8, respectively) demon-
strate that titin protein exchange occurs within one myofibril 
as well as between adjacent myofibrils at similar rates (Fig. 5,   
D and E). Furthermore, we found similar kinetics comparing 
lateral and longitudinal titin movement as indicated by the ex-
change half-lives of protein mobility (Fig. 5, D and E). Thus, 
titin mobility has more than one degree of freedom and is equally 
efficient along and across the sarcomere.
Calcium levels affect titin mobility
It has previously been shown that calcium does not only affect the 
proliferation of cardiomyocytes and protein expression, but also 
changes the mobility of sarcomeric proteins (Harayama et al., 
1998). To investigate the effect of calcium on the mobility of titin 
we exposed embryonic cardiomyocytes to three different calcium 
concentrations (low, 0.9 mM; normal, 1.8 mM; high, 2.8 mM). 
Recovery was facilitated at reduced calcium levels, whereas treat-
ment with high calcium resulted in a depressed recovery curve 
(Fig. 6, A and B). Differences in calcium-dependent recovery   
after photobleaching were largely attributable to differences in 
the mobile fractions, with 72 ± 4% at low calcium vs. 49 ± 4% at 
normal and 28 ± 5% at high calcium levels (Fig. 6 C). Calculated 
half-lives of titin-eGFP recovery after photobleaching were not 
significantly different (Table I). These data suggest that calcium 
levels determine the stability of titin’s integration in the sarco-
mere, rather than the movement of titin within the myofilament. 
To differentiate effects of calcium mediated by myosin or con-
traction versus signal transduction, we used 2,3-butanedione 
monoxime (BDM) as a cell-permeable inhibitor of myosin II. As 
indicated in Fig. 7, there was no effect of BDM on titin mobility 
comparing  beating  and  BDM-treated  cardiomyocytes  (Fig.  7,   
B and C). Furthermore, the effect of high calcium was not 
overcome by BDM treatment (Fig. 7, D and E), both arguing 
for a myosin- and contraction-independent effect.
Comparison of titin-eGFP mobility in 
embryonic and neonatal cardiomyocytes
Titin protein undergoes a perinatal isoform switch leading to the 
expression of shorter titin isoforms starting at the day of birth 
(Greaser et al., 2005). We confirmed this difference in titin isoform 
expression by qPCR and found a significantly higher expression of 
Table II.  Mobile fractions (Mf) and exchange half-lives (t1/2) of titin-
eGFP related to area of photobleaching
Bleached area [s.l.] Mf [%] t1/2 [h]
1 × 1 49 ± 4 2.1 ± 0.4
3 × 3 61 ± 2 6.1 ± 1.3
8 × 8 52 ± 7 8.2 ± 2.4*
s.l.: sarcomere length (n = 11).
*, P < 0.05; one-way ANOVA, posttest Dunnett (comparison vs. 1 × 1). Data 
are indicated as means ± SEM.791 Visualizing titin dynamics • da Silva Lopes et al.
Titin—more than a static scaffold
Sarcomeres are highly ordered and therefore appear as a sta-
ble structure. Nevertheless, there is a continuous movement of 
structural, adaptor, signaling, and metabolic proteins to and 
from the sarcomere. Here we examine how titin, as a protein 
that builds the sarcomeric backbone, is replaced and travels 
proper integration of titin into the M-band or sarcomere as-
sembly and maintenance. Attaching eGFP to the C terminus 
only labels full-length titin, but not the shorter (up to 700 kD) 
novex isoforms (Bang et al., 2001). Accordingly, we specifi-
cally visualize the pool of titin isoforms that contribute to 
the continuous titin filament system.
Figure 5.  Longitudinal and lateral movement of titin-
eGFP within the sarcomere. (A) Bleaching of 3 or 8 
consecutive sarcomeres in embryonic cardiomyocytes 
was  used  to  study  longitudinal  (white  arrows)  and 
lateral (open arrows) mobility of titin-eGFP. Titin-eGFP   
dynamics  was  monitored  for  14  h.  Bar,  10  µm. 
(B  and  C)  Lateral  and  longitudinal  movement  of 
titin-eGFP were equally efficient as demonstrated by 
the plot of fluorescence intensity vs. time after photo-
bleaching of 3 or 8 sarcomeres (3 sarcomeres, n = 4; 
8 sarcomeres, n = 3). (D and E) The titin-eGFP mobile 
fractions were independent from the shape and area 
of  photobleaching,  whereas  the  half-fluorescence   
recovery increases with the size of the bleached area 
(3 sarcomeres, n = 4; 8 sarcomeres, n = 3). Error bars 
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Nevertheless, we did not see a drift of the bleached area within 
the cell or major changes in its shape, which we would expect if 
fluorescence recovery was driven by rearrangement only. Based 
on the directionality of the sarcomere, we would expect differ-
ences in rearrangements or titin mobility along and across the 
myofiber, unless titin molecules are detached, relocate passively, 
and get reattached as outlined below.
Titin spans the half-sarcomere integrating with its N ter-
minus into the Z-disc and with its C terminus into the M-band 
overlapping  head-to-head  and  tail-to-tail  (Fürst  et  al.,  1988; 
Wang et al., 1991; Labeit et al., 1997). The longitudinal move-
ment of titin along the sarcomere would therefore require titin 
to disconnect and reconnect in an antiparallel orientation at the 
succeeding next half-sarcomere. For lateral movement of titin 
the protein remains within the half-sarcomere with neighboring 
titin molecules trading places as N termini and C termini move 
along the Z-disc and M-band, respectively. This should be re-
flected in different kinetics comparing lateral and longitudinal 
mobility of titin-eGFP. Following the argument that an area 
with more lateral neighboring titin-eGFP molecules would more 
efficiently detect lateral movement versus an area with more lon-
gitudinal  neighboring  titin-eGFP,  we  compared  laterally  and 
longitudinally oriented regions of interest to differentiate the 
direction of titin mobility (Fig. 4). As regions of similar size 
were repopulated with similar kinetics—independent of their 
orientation  within  the  cardiomyocyte—we  suggest  a  model 
where titin is detached from the M-band and Z-disc and freely 
within the sarcomere. It has been known for decades that the 
synthetic half-lives of sarcomeric proteins vary considerably 
and range from 3 to 10 d (Zak et al., 1977; Isaacs et al., 
1989). These proteins are thus replaced at different rates—
either within the sarcomere or after relocalization to the pro-
teasome with a constant exchange between the sarcomeric and 
the cytoplasmic pool. Here, we used FRAP analysis of primary 
cardiomyocytes to study titin mobility. Cultured cells appeared 
normal, were contracting spontaneously, and remained stable 
throughout the photobleaching experiments. The recovery of   
titin-eGFP was much faster than expected based on the pub-
lished synthetic half-life for newly synthesized titin protein of 
2.9 d (Isaacs et al., 1989). We concluded that recovery after 
photobleaching was largely attributable to the movement of ex-
isting titin proteins within the sarcomere or cytoplasmic pool 
versus the integration of newly synthesized titin-eGFP protein 
into the sarcomere. This was confirmed by addition of CX to the 
media, which inhibits protein synthesis but does not signifi-
cantly alter fluorescence recovery.
Sarcomere dynamics
Mobility of titin could either reflect relocalization of individual 
titin molecules or rearrangement of myofibrils. Although we 
did not detect major structural changes of the filament system in 
the 14-h time-lapse (compare Fig. S2 and Video 1), minor changes 
in location of the myofibril might occur—in part because the 
cells contract and also as cells shift position in culture over time. 
Figure 6.  Calcium interferes with titin-eGFP dy-
namics. (A) Images of embryonic cardiomyocytes 
(E13.5) maintained at low vs. high calcium levels 
(0.9 mM LCa vs. 2.8 mM HCa) were obtained 
before  and  immediately  after  bleaching  (white 
arrows). 14 h after bleaching the titin-eGFP sig-
nal was recovered only partially in cells treated 
with high as compared with low calcium. Bar,   
10 µm. (B) Recovery profile of the bleached re-
gion over time. The titin-eGFP mobility was sig-
nificantly increased at low calcium concentration 
and decreased at high calcium concentration as 
compared with control cells (normal, NCa, 1.8 mM;   
n = 4). (C) Mobile fractions decreased with in-
creasing levels of calcium (n = 4 per group). *, 
P < 0.05; **, P < 0.01; ***, P < 0.001. Error bars 
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of cardiomyocytes and affect expression of sarcomeric proteins 
(Harayama et al., 1998). Within the sarcomere calcium activates 
contraction (Allen and Blinks, 1978) and regulates not only the 
interaction of actin and myosin, but also of titin and actin. High 
calcium levels increase the titin–actin interaction, which has 
been speculated to introduce a viscous force component oppos-
ing actin–myosin filament sliding (Kellermayer and Granzier, 
1996; Linke et al., 2002). Furthermore, calcium binding to   
titin’s glutamate-rich PEVK exons leads to stiffening of the 
PEVK element (Labeit et al., 2003; Fujita et al., 2004). These 
data suggest that calcium levels determine the stability of titin’s 
integration in the sarcomere, rather than the transport of titin 
within the myofilament. Both the remodeling of the sarcomere 
with increased proliferation and the increased interaction with 
actin could affect titin’s mobility in the sarcomere. The former 
would be expected to increase titin mobility as sarcomeres dis-
assemble, the calcium-dependent increase in titin–actin inter-
action would conversely lead to lower motility with increased 
calcium levels. Our data indeed show decreased titin mobility 
moves in either direction before it reintegrates. Independently, 
we followed recovery after photobleaching of the 8 × 8 square 
and found that titin-eGFP movement into the bleached area was 
equally efficient from either side, supporting our findings from 
the  directional  photobleaching  (Fig.  S2; Video  1).  Thus,  we 
would suggest that a soluble or unattached pool of titin (de novo 
synthesized or under migration) is distinct from a sarcomeric or 
attached pool of titin that is tightly integrated into the myofila-
ment and that the unattached titin would freely move along and 
within the myofiber.
Calcium-dependent titin mobility
Calcium is a universal intracellular second messenger. Its mul-
tiple functions in the cardiomyocyte relate to electrophysiology, 
excitation–contraction coupling, contraction and relaxation, en-
ergy consumption, and cell growth and death, as well as transcrip-
tional regulation (Bers, 2008). Toward understanding the effect 
of calcium on titin dynamics, it has been shown that low cal-
cium concentrations in the culture media enhance the proliferation 
Figure 7.  Titin-eGFP dynamics in cardiomyocytes is in-
dependent from contractility. (A) Cardiomyocytes were   
treated with the myosin inhibitor 2,3-butanedione 
monoxime (BDM), maintained in a high calcium con-
centration (HCa, 2.8 mM), or treated with a combina-
tion of BDM and 2.8 mM calcium. Selected regions 
from  nonbeating  cells  expressing  titin-eGFP  were 
photobleached. Bar, 10 µm. (B and C) The fluores-
cence recovery was monitored over time. The mobility 
of titin-eGFP of nonbeating cells was equally efficient 
compared with beating control cells (control, n = 4; 
BDM, n = 3). (D and E) FRAP analysis with BDM treat-
ment was repeated in cells cultured in medium with 
high calcium levels. The decreased dynamics of titin-
eGFP could not be rescued by inhibition of contraction 
(control, n = 4; BDM + HCa, n = 3). *, P < 0.05. 
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cardiomyocytes were very sensitive to photobleaching and did 
not survive the FRAP procedure. Because titin displays a simi-
lar mobility in embryonic and neonatal cardiomyocytes at a 
time where the main changes in titin isoform expression and 
functional adaptation of the cardiomyocyte take place (Lahmers   
et al., 2004; Opitz et al., 2004; Warren et al., 2004), an addi-
tional change in the dynamics of titin in adult cardiomyocytes 
was not expected.
Comparative sarcomere dynamics
In FRAP experiments, the exchange of bleached by unbleached 
proteins occurs much faster than protein turnover would sug-
gest, which reflects the contribution of protein movement ver-
sus de novo synthesis. Previous studies of sarcomere dynamics 
have shown a considerable difference in protein mobility with 
half-fluorescence recovery ranging from <1 to 12 min (Wang 
et al., 2005a), possibly related to different binding affinities or 
numbers of binding partners. Comparing FRAP of sarcomeric 
proteins allows speculation on structural functions versus a role 
in more dynamic processes such as signal transduction or 
metabolism. Within the Z-disc, the quick recovery after photo-
bleaching of myotilin and -actinin as compared with T-cap 
suggests a structural role for the latter (Wang et al., 2005a). Un-
like various sarcomeric proteins studied previously, the half-
fluorescence recovery of titin is in the range of hours (titin 2 h vs. 
T-cap 5 min), which further substantiates the role of titin as 
the sarcomeric backbone.
Actin mobility has been studied extensively with half-
fluorescence recovery ranging from 1 to 60 min between -actin 
in neonatal rat cardiomyocytes (Skwarek-Maruszewska et al., 
2009) versus G-actin in skeletal muscle (Suzuki et al., 1998; 
Hasebe-Kishi and Shimada, 2000). Skeletal muscle -actinin 
(rabbit) microinjected into embryonic chicken cardiomyocytes 
does hardly recover after photobleaching, but almost completely 
recovers in fibroblasts (Hasebe-Kishi and Shimada, 2000). The 
available literature on sarcomeric protein mobility suggests that 
both mobile fractions and exchange half-lives depend on the 
with increased calcium levels that would be consistent with a 
stronger retention of titin at the actin filament system. Neverthe-
less, the calcium-dependent interaction between titin and actin 
is relatively weak and may suggest that the titin–actin inter-
action is insufficient to explain the improved FRAP at reduced 
calcium levels we describe here (Linke et al., 2002). Alterna-
tively, the effect of calcium on titin motility might be mediated 
by altered calcium signaling and transcriptional regulation. As 
suitable tools become available to dissect the effects of calcium 
on signal transduction and protein–protein interaction, it should 
be possible to determine their relative contribution to stabilizing 
titin in the sarcomere.
Titin movement in the developing sarcomere
The pattern of cardiac protein expression changes during devel-
opment and several sarcomeric proteins switch their isoform 
type perinatally. Thus, in rat ventricle the predominant fetal iso-
form -myosin heavy chain (-MHC) is replaced by -MHC 
after birth (Lompré et al., 1984). Similarly, the -skeletal actin 
isoform, which is coexpressed with -cardiac actin before birth, 
is gradually replaced with the -cardiac actin isoform in post-
natal development (Carrier et al., 1992). A similar isoform switch of 
sarcomeric proteins has been described for troponin-I, troponin-T, 
tropomyosin, and the titin M-band–binding protein myomesin 
(Grove et al., 1985; Saggin et al., 1988, 1989; Agarkova et al., 
2000; Metzger et al., 2003). Cardiac titin is intensively alterna-
tively spliced during development and postnatally. In the em-
bryonic mouse heart the major titin isoform is N2BA—opposed 
to the adult heart with mainly N2B titin and neonatal hearts, 
which express both isoforms (Lahmers et al., 2004; Opitz et al., 
2004; Warren et al., 2004). We used FRAP of titin-eGFP knockin 
cardiomyocytes to evaluate if these changes in isoform expres-
sion and protein makeup of the embryonic as compared with the 
neonatal heart lead to altered titin dynamics. The comparison of 
cardiomyocytes at different stages of development did not indi-
cate  a  difference  in  FRAP,  suggesting  that  titin’s  motility  is 
largely independent from its domain composition. Isolated adult 
Figure  8.  Titin-eGFP  dynamics  in  neonatal  cardio-
myocytes. (A) FRAP was completed within 14 h in neona-
tal cardiomyocytes (NCM) prepared on postnatal day 
two (P2). White arrows indicate the bleached regions. 
Bar, 10 µm. (B) Comparison of embryonic vs. neona-
tal cardiomyocytes (ECM E13.5 vs. NCM P2) did not 
reveal a significant difference (ECM, n = 4; NCM,   
n = 3). (C) There was no difference in mobile fractions 
between  neonatal  and  embryonic  cardiomyocytes 
(ECM, n = 4; NCM, n = 3). Error bars indicate SEM.795 Visualizing titin dynamics • da Silva Lopes et al.
SDS-agarose electrophoresis and Western blot
Vertical SDS-agarose gel electrophoresis (VAGE) was used to detect titin-
eGFP in cardiac and skeletal muscle (quadriceps and soleus) of adult 
knockin mice (Warren et al., 2003). For Western blot analysis the pro-
teins were transferred to a PVDF membrane (GE Healthcare) with the 
PerfectBlue Semi-Dry Electroblotter SEDEC M (PEQLAB) at 250 mA for 
1.5 h using anode buffer I (300 mM Tris-base, 0.05% SDS, and 10% 
methanol, pH 10.4), anode buffer II (25 mM Tris-base, 0.05% SDS, and 
10% methanol, pH 10.4), and cathode buffer (25 mM Tris-base, 0.05% 
SDS, 10% methanol, 40 mM caproic acid, and 10 mM -mercaptoethanol, 
pH 10.4). The membrane was blocked with blocking solution (10 mM 
Tris/HCl, pH 8, 150 mM NaCl, 0.1% Tween 20, 0.5% BSA, and 2.5% 
skim milk) followed by incubation with the polyclonal primary antibody 
anti-GFP  (1:1,000  in  blocking  solution;  Abcam),  anti-titin  Z1/Z2 
(1:1,000), or anti-titin M8/M9 (1:500; Trombitás et al., 2000) at 4°C 
overnight. Both titin antibodies were gifts from S. Labeit (Universitätsklini-
kum Mannheim, Mannheim, Germany). HRP-conjugated goat anti–rabbit 
IgG (1:2,500 in blocking solution; Sigma-Aldrich) was used as second-
ary  antibody.  Blots  were  washed  twice  with  PBS-Tween  20  followed   
by a PBS wash and developed by chemiluminescence staining using 
ECL  (SuperSignal  West  Femto  Chemiluminescent  Substrate;  Thermo 
Fisher Scientific). Images were taken using the Stella 8300 imaging sys-
tem (Raytest) and processed using the Aida Image Analyzer v.2.24 soft-
ware (Raytest).
Real-time PCR
Heart and skeletal muscle from adult titin-eGFP wild-type, heterozygous, 
and homozygous mice were used for isolation of total RNA. Primary em-
bryonic (E13.5) and neonatal cardiomyocytes (P2) from homozygous titin-
eGFP mice were cultured for 3 d and used for RNA isolation. Snap-frozen 
tissue was homogenized two times for 2 min at a frequency of 30/s using 
the TissueLyser II (QIAGEN). RNA was isolated using the peqGOLD TriFast 
kit (peqlab) and the RNeasy Mini kit (QIAGEN), followed by digestion of 
contaminating genomic DNA (RNase-Free DNase Set; QIAGEN). RNA 
concentration and purity were determined by spectrophotometry. 3 µg of 
total RNA was used for cDNA synthesis (Thermoscript First-Strand Synthesis 
System; Invitrogen). Quantitative real-time RT-PCR was performed using the 
TaqMan probe-based chemistry (Applied Biosystems). Real-time PCR ampli-
fication reaction was performed on a Sequence Detection System (7900 HT; 
Applied  Biosystems)  using  the  qPCR  MasterMix  Plus  (Eurogentec)   
according to the manufacturer’s instructions with 1x TaqMan Universal PCR 
master mix, 900 nM primers (EGFP-for 5-CTGCTGCCCGACAACCAC-3, 
EGFP-rev 5-ACCATGTGATCGCGCTTCTC-3; Mex3-4-for 5-CCCCTGAAA-
TTGAGTGGTTTAAA-3,  Mex3-4-rev  5-TTCTGGAGCGACTCACACTGA-3; 
Z1/Z2-for 5-CGATGGCCGCGCTAGA-3, Z1/Z2-rev 5-CTCAGGGAG-
TATCGTCCACTGTT-3; N2B-for 5-GCAAAGCCTCCAATGAGTATGG-3, 
N2B-rev 5-AGGAAGTAATTTACGAACTTTCTTTTCAG-3; N2BA-for 5-ACA-
GTGGGAAAGCAAAGACATC-3,  N2BA-rev  5-AGGTGGCCCAGAGC-
TACTTC-3;  endogenous  control  18S  RNA-for  5-CGCCGCTAGAGGT-
GAAATTC-3, 18S RNA-rev 5-TGGGCAAATGCTTTCGCTC-3), and 250 nM   
of  probe  (EGFP-probe  6-FAM-CCAGTCCGCCCTGAGCAAAGACC-
TAMRA;  Mex3-4-probe  6-FAM-AACCTTCCAATTTCCATTTCTTCA-TAMRA; 
Z1/Z2-probe  6-FAM-TGATGATCCCCGCCGTGACTAAAGC-TAMRA;  N2B- 
probe 6-FAM-TGCACAGCCACACTAACTGTGACAGTGC-TAMRA; N2BA-
probe 6-FAM-GAAAGAGCTGCCCCTGTGATCA-TAMRA; 18S RNA-probe 
6-FAM-TGGACCGGCGCAAGACGGAC-TAMRA). Thermal cycling condi-
tions were as follows: 50°C for 2 min, 95°C for 10 min followed by 50   
cycles of 95°C for 10 s, and 60°C for 1 min. Data were collected and ana-
lyzed with Sequence Detection System 2.3 software (Applied Biosystems). 
The comparative CT method (CT method) was used as described in the 
User Bulletin 2: ABI PRISM 7700 Sequence Detection System.
Immunofluorescence staining
Adult  tissues  from  wild-type,  homozygous,  and  heterozygous  titin-eGFP 
mice  were  dissected  and  used  for  immunofluorescence  staining  as  de-
scribed previously (Weinert et al., 2006) with the following changes. Tis-
sues were fixed in 4% PFA for 6 h, equilibrated with 30% sucrose in PBS 
overnight, and embedded in Tissue Tek (O.C.T. compound; Sakura). Cryo-
sections (5 µm) were blocked and permeabilized in blocking solution (10% 
goat serum, 0.3% Triton X-100, and 0.2% BSA in PBS) for 1 h. The sections 
were incubated with primary antibodies at 4°C overnight followed by the 
incubation with a biotin-conjugated antibody (1:500; BD) at room temper-
ature for 1 h. Labeling with the fluorescent secondary antibody streptavidin 
A647 (1:1,000; Invitrogen) was performed at room temperature for 1 h. 
Primary antibodies were used at the following dilutions: 1:200 monoclonal 
species, cell type, and stage of development, although some of 
the variation could certainly result from experimental differ-
ences, species differences, or the amount of labeled protein 
after injection or overexpression. The knockin approach pre-
sented here provides the advantage of physiological levels of 
the labeled protein and normal regulation. Nevertheless, it is 
technically demanding, difficult to apply in a high throughput 
format, and might not provide detectable amounts of label for 
proteins expressed at lower levels. Titin is an ideal candidate for 
the knockin strategy as the locus is readily available for gene 
targeting and based on its robust expression in striated muscle 
(Weinert et al., 2006; Radke et al., 2007; Gramlich et al., 2009; 
Granzier et al., 2009).
Using these unique advantages, we were able to produce a 
tagged version of the >3 MDa titin holoprotein for live imaging 
and obtained novel insights into its role in sarcomere biology. 
We show that titin travels equally efficient along and within the 
myofiber—consistent with a model where titin is detached from 
the M-band and Z-disc and freely moves in either direction   
before it reintegrates into the sarcomere. Titin recovery is inde-
pendent from protein synthesis and its mobility is maintained 
through  development  but  inversely  correlates  with  calcium 
levels. We conclude that the giant titin protein is much more dy-
namic than previously expected based on its size and function in 
the sarcomere.
Materials and methods
Generation of titin-eGFP knockin mice
A targeting construct to replace the stop codon in titin’s M-band exon 6 
with the eGFP cDNA (maintaining the open reading frame) was generated 
using standard procedures. The neomycin (Neo) resistance cassette was 
integrated into the 3 untranslated region (Fig. 1). In brief, M-band exons 
5 and 6 and the 3 untranslated region were amplified from genomic 
DNA with suitable restriction sites included in the primer sequence. The 
targeting vector was assembled and verified by restriction digest and se-
quence analysis. Embryonic stem cells (AB1) were transfected by electro-
poration with the linearized targeting vector and selected with G418 as 
described previously (Gotthardt et al., 2003). Individual colonies were 
expanded  and  analyzed  for  homologous  recombination  by  PCR  and 
Southern blot (0.6% of neomycin resisted clones). After blastocyst injection 
and germline transmission, the Neo cassette was excised using the Flp 
FRT recombination system. Animals were backcrossed on a 129/S6 
background and for each experiment littermates were used (age and 
sex matched).
Genotyping
Genomic DNA was prepared from mouse tail following standard proce-
dures. Proper integration of the eGFP construct into the titin locus was moni-
tored by PCR using primers SAK-for (5-GCCCTTGTAAGACTTTCCAGAAT-3) 
and EGFP-rev (5-AGATGAACTTCAGGGTCAGCTTG-3). Excision of the 
Neo selection marker was confirmed using primers EGFP-for (5-GTCCT-
GCTGGAGTTCGTGAC-3)  and  FRT-rev  (5-CAGGTCAAGTATGAAAGGA-
TTGC-3). The Flp recombinase allele was detected using primers Flp-for 
(5-GTCACTGCAGTTTAAATACAAGACG-3)  and  Flp-rev  (5-GTTGCGC-
TAAAGAAGTATATGTGCC-3). Titin wild-type and titin-eGFP loci were typed 
using primers Mex6SAi-for (5-AGAACAACAAGGAAGATTCCACA-3), 
SAK-rev (5-TCTCAACCCACTGAGGCATA-3), and EGFP-rev.
Animal procedures
The body weight of age- and gender (female)-matched wild-type, hetero-
zygous, and homozygous titin-eGFP mice was determined. Animals were 
sacrificed by cervical dislocation. Hearts were retrieved to calculate the 
heart weight to body weight ratio. All experiments involving animals were 
performed following the rules for Animal Welfare of the German Society 
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Mf is the mobile fraction and is calculated with the following equation:
	 	 	(4)
Fend is the fluorescence intensity when the recovery has reached the pla-
teau level. Fpre is defined as the fluorescence intensity before and Fpost 
after photobleaching. FRAP data are displayed as mean of 3–4 individ-
ual experiments.
Cycloheximide, calcium, and BDM treatment
Cycloheximide (CX; Sigma-Aldrich) is a general inhibitor of protein synthe-
sis that blocks elongation of translation. 10 µg/ml of CX were included in 
the media. Cells were incubated in CX for 1 h before and during the FRAP 
experiment (Zaal et al., 1999).
The role of calcium on the FRAP was evaluated by various calcium 
concentrations in the culture medium as described in Harayama et al. 
(1998). In short, embryonic cardiomyocytes were isolated and after precul-
ture for 3 d 0.9 mM (low, LCa), 1.8 mM (normal, NCa; control), or 2.8 mM 
(high, HCa) of calcium were added to the culture medium. The treatment 
was repeated after 2 d. On the fifth day of treatment the cells were used 
for FRAP analysis.
To differentiate an effect of calcium on signaling or protein binding 
versus contraction, we treated cardiomyocytes with the myosin inhibitor 
2,3-butanedione  monoxime  (BDM;  Sigma-Aldrich).  FRAP  experiments 
were performed 15 min after addition of 15 mM BDM, when cells had 
stopped beating.
Statistical analysis
Differences between two groups were assessed by t test and between three 
groups  by  one-way  ANOVA.  Groups  affected  by  two  factors  were   
assessed by two-way ANOVA. For statistical analysis we used Prism 5.0 
(GraphPad Software). Significance was set at a probability value of 0.05. 
All results are expressed as mean ± SEM.
Online supplemental material
Fig. S1 shows Western blot analysis of the expression of titin-eGFP in striated 
muscle. Fig. S2 provides time-lapse images documenting the fluorescence re-
covery of titin-eGFP in a larger bleached area. Fig. S3 confirms the differ-
ences in titin isoform expression in neonatal as compared with embryonic 
cardiomyocytes. Video 1 is a time-lapse video showing the FRAP analysis of 
titin-eGFP in a larger bleached area. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201010099/DC1.
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anti-sarcomeric -actinin (Sigma-Aldrich), 1:50 anti-titin Z1/Z2, and 1:200 
anti-titin M8/M9 (Trombitás et al., 2000). Fluorescence images were 
acquired with a laser-scanning confocal microscope (LSM 510 with software 
3.2 SP2; Carl Zeiss) with a Plan-Apochromat 100x/1.4 oil DIC objective 
(Carl Zeiss). Images were assembled using Adobe Photoshop and Adobe 
Illustrator CS5.
Isolation of embryonic and neonatal murine cardiomyocytes
Timed  matings  were  set  up  between  homozygous  animals  (G/G).  The 
morning of detection of the vaginal plug was regarded as day 0.5 after 
conception. Embryos were harvested at E13.5. The hearts were dissected 
and digested with 0.05% trypsin/EDTA (Invitrogen) for 2–4 h at 4°C fol-
lowed by incubation at 37°C for 15 min. After centrifugation at 800 g for 
3 min, the cells were resuspended in DME (Cambrex) supplemented with 
10% fetal bovine serum (FBS; Sigma-Aldrich), 1% penicillin/streptomycin 
(Invitrogen), and 1% nonessential amino acids (Invitrogen), and plated 
onto 0.1% gelatin-coated plastic dishes (ibidi). The culture was maintained 
at 37°C and 5% CO2 until transfer for FRAP experiments.
Neonatal (P2) hearts from homozygous titin-eGFP mice were dis-
sected and pooled. Hearts were cut into small pieces, washed with PBS, 
and digested with 2.5 ml of 0.25% trypsin/EDTA (Invitrogen) at 34°C for 
3 min. Trypsin solution was replaced and the tissue was incubated in 2.5 ml 
0.25% trypsin/EDTA at 37°C for an additional 10 min. The supernatant 
was collected and the digestion was stopped with 1.25 ml of cold FBS. 
After centrifugation at 1,000 rpm for 8 min the pellet was resuspended 
in 750 µl DME and 750 µl FBS and stored on ice. The trypsinization was 
repeated until full digestion of the hearts. All fractions were pooled and 
centrifuged at 1,000 rpm for 10 min. The pellet was resuspended in DME 
(Cambrex) supplemented with 10% FBS, 1% penicillin/streptomycin (Invi-
trogen), and 1% nonessential amino acids (Invitrogen) and plated onto 
0.1% gelatin-coated plastic dishes (ibidi). The culture was maintained at 
37°C and 5% CO2.
Fluorescence recovery after photobleaching and analysis of FRAP data
FRAP experiments were performed with a laser-scanning confocal micro-
scope (LSM 510 Meta; Carl Zeiss). Titin-eGFP homozygous primary cardio-
myocytes were kept at 37°C and 5% CO2 using a CO2 microscope cage 
incubation system (Okolab). For eGFP imaging the excitation wavelength 
and emission filters were 488 nm/band-pass 500–550 nm. Image pro-
cessing was performed using LSM 510 Image Browser version 4.2 (Carl 
Zeiss). For FRAP experiments a Plan-Apochromat 63x/1.4 oil Ph3 objec-
tive was used and the confocal pinhole was set to 1.5 µm. 3–4 experi-
ments (n = 3–4) were performed and each time 4–10 cells were selected. 
For every cell 1 or 2 different regions of interest (ROI) were chosen for 
bleaching to keep phototoxicity low and areas of interest were limited to 
squares of 1, 3, or 8 sarcomere lengths or areas of 1 sarcomere length × 3 
or  8  sarcomere  lengths  along  or  across  the  myofiber.  Images  were 
taken  before  and  immediately  after  bleaching.  Photobleaching  was 
done with 100% intensity of the 488-nm laser for 20 iterations. The fluores-
cence recovery was monitored 14 times every hour and measured using 
the LSM Image Examiner (Carl Zeiss). Normalized FRAP curves were 
generated from raw data as described in Al Tanoury et al. (2010). Back-
ground intensity (Ibase(t)) was measured in a region outside of the cell and 
then subtracted from the intensity of the bleached area (Ifrap(t)) and the 
whole cell (Iwhole(t)) at each time point. The intensities were then normal-
ized by rescaling to the prebleach intensities in the corresponding regions 
(Ifrap-pre, and Iwhole  pre). The resulting equation for the normalized FRAP 
curve is:
	 	 	(1)
To obtain the exchange half-life (t1/2) data were displayed as normalized 
fluorescence intensity versus time using Prism 5.0 (GraphPad Software). 
The model of one phase association was applied to fit the data:
	 	 	(2)
The fluorescence intensity at time zero after bleaching is defined as y0. K is 
the rate constant. The exchange half-life (t1/2) is computed as follows:
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